Protective effects of placental growth factor on retinal neuronal cell damage

Journal of Neuroscience Research

Volumn 92, Issue 3, 2014, Pages 329-337

  Inoue, Yuki ^a   Shimazawa, Masamitsu ^a   Nakamura, Shinsuke ^a,b   Imamura, Tomoyo ^a   Sugitani, Sou ^a   Tsuruma, Kazuhiro ^a   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b NOVARTIS PHARMA K K   (Japan)

Author keywords

Growth factor; Neuroprotection; PlGF; Retinal damage

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CASPASE 7; HOE 33342; PLACENTAL GROWTH FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; IRRADIATION; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL;

GROWTH FACTOR; NEUROPROTECTION; PLGF; RETINAL DAMAGE;

ANIMALS; ANOXIA; CASPASE 3; CELL DEATH; CELL LINE, TRANSFORMED; ENZYME INHIBITORS; GLUCOSE; GLUTAMIC ACID; MICE; NEUROPROTECTIVE AGENTS; PREGNANCY PROTEINS; RETINAL NEURONS;

EID: 84892478651     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23316     Document Type: Article

References (52)

1. Autiero M, Luttun A, Tjwa M, Carmeliet P. 2003. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1:1356-1370.
2. Balaiya S, Ferguson LR, Chalam KV. 2012. Evaluation of sirtuin role in neuroprotection of retinal ganglion cells in hypoxia. Invest Ophthalmol Vis Sci 53:4315-4322.
3. Bonne C, Muller A, Villain M. 1998. Free radicals in retinal ischemia. Gen Pharmacol 30:275-280.
4. Choudhury S, Bhootada Y, Gorbatyuk O, Gorbatyuk M. 2013. Caspase-7 ablation modulates UPR, reprograms TRAF2-JNK apoptosis and protects T17M rhodopsin mice from severe retinal degeneration. Cell Death Dis 4:e528.
5. den Hollander AI, Roepman R, Koenekoop RK, Cremers FP. 2008. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Ret Eye Res 27:391-419.
6. Dreyer EB. 1998. A proposed role for excitotoxicity in glaucoma. J Glaucoma 7:62-67.
7. Du H, Li P, Pan Y, Li W, Hou J, Chen H, Wang J, Tang H. 2010. Vascular endothelial growth factor signaling implicated in neuroprotective effects of placental growth factor in an in vitro ischemic model. Brain Res 1357:1-8.
8. Englund-Johansson U, Mohlin C, Liljekvist-Soltic I, Ekstrom P, Johansson K. 2010. Human neural progenitor cells promote photoreceptor survival in retinal explants. Exp Eye Res 90:292-299.
9. Feeney SA, Simpson DA, Gardiner TA, Boyle C, Jamison P, Stitt AW. 2003. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression. Invest Ophthalmol Vis Sci 44:839-847.
10. Fischer C, Mazzone M, Jonckx B, Carmeliet P. 2008. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8:942-956.
11. Galindo-Romero C, Valiente-Soriano FJ, Jimenez-Lopez M, Garcia-Ayuso D, Villegas-Perez MP, Vidal-Sanz M, Agudo-Barriuso M. 2013. Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia. Invest Ophthalmol Vis Sci 54:974-985.
12. Gordon N. 1959. Ocular manifestations of internal carotid artery occlusion. Br J Ophthalmol 43:257-267.
13. Han BH, Holtzman DM. 2000. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 20:5775-5781.
14. Hedges TR Jr. 1963. Ophthalmoscopic findings in internal carotid artery occlusion. Am J Ophthalmol 55:1007-1012.
15. Imai S, Inokuchi Y, Nakamura S, Tsuruma K, Shimazawa M, Hara H. 2010. Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina. Eur J Pharmacol 642:77-85.
16. Inokuchi Y, Imai S, Nakajima Y, Shimazawa M, Aihara M, Araie M, Hara H. 2009. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo. J Pharmacol Exp Ther 329:687-698.
17. Inoue Y, Tsuruma K, Nakanishi T, Oyagi A, Ohno Y, Otsuka T, Shimazawa M, Hara H. 2013. Role of heparin-binding epidermal growth factor-like growth factor in light-induced photoreceptor degeneration in mouse retina. Invest Ophthalmol Vis Sci 54:3815-3829.
18. Jager RD, Mieler WF, Miller JW. 2008. Age-related macular degeneration. N Engl J Med 358:2606-2617.
19. Jin KL, Mao XO, Greenberg DA. 2000. Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal. J Mol Neurosci 14:197-203.
20. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM. 2005. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 19:2026-2028.
21. Kilic U, Kilic E, Jarve A, Guo Z, Spudich A, Bieber K, Barzena U, Bassetti CL, Marti HH, Hermann DM. 2006. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci 26:12439-12446.
22. Kwon YH, Fingert JH, Kuehn MH, Alward WL. 2009. Primary open-angle glaucoma. N Engl J Med 360:1113-1124.
23. Landgren E, Schiller P, Cao Y, Claesson-Welsh L. 1998. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt1. Oncogene 16:359-367.
24. LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos GD, Steinberg RH. 1992. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci U S A 89:11249-11253.
25. 2+, caspase-3/7, and morphological changes in retinal ganglion cell apoptosis under elevated pressure. PLoS One 5:e13437.
26. Li G, Anderson RE, Tomita H, Adler R, Liu X, Zack DJ, Rajala RV. 2007. Nonredundant role of Akt2 for neuroprotection of rod photoreceptor cells from light-induced cell death. J Neurosci 27:203-211.
27. Li H, Wang B, Zhu C, Feng Y, Wang S, Shahzad M, Hu C, Mo M, Du F, Yu X. 2013. 17Beta-estradiol iompedes Bax-involved mitochondrial apoptosis of retinal nerve cells induced by oxidative damage via the phosphatidylinositol 3-kinase/Akt signal pathway. J Mol Neurosci 50:482-493.
28. Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H, Kocsis JD. 2006. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 129:2734-2745.
29. Luo Y, DeFranco DB. 2006. Opposing roles for ERK1/2 in neuronal oxidative toxicity: distinct mechanisms of ERK1/2 action at early versus late phases of oxidative stress. J Biol Chem 281:16436-16442.
30. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P. 2002. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8:831-840.
31. Ma Y, Lu C, Li C, Li R, Zhang Y, Ma H, Zhang X, Ding Z, Liu L. 2013. Overexpression of HSPA12B protects against cerebral ischemia/reperfusion injury via a PI3K/Akt-dependent mechanism. Biochim Biophys Acta 1832:57-66.
32. Nakanishi T, Shimazawa M, Sugitani S, Kudo T, Imai S, Inokuchi Y, Tsuruma K, Hara H. 2013. Role of endoplasmic reticulum stress in light-induced photoreceptor degeneration in mice. J Neurochem (in press).
33. Nakanishi Y, Nakamura M, Mukuno H, Kanamori A, Seigel GM, Negi A. 2006. Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase. Exp Eye Res 83:1108-1117.
34. Neufeld AH. 1999. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma. Surv Ophthalmol 43(Suppl 1):S129-S135.
35. Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP, Shima DT. 2007. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171:53-67.
36. Oyagi A, Morimoto N, Hamanaka J, Ishiguro M, Tsuruma K, Shimazawa M, Hara H. 2011. Forebrain specific heparin-binding epidermal growth factor-like growth factor knockout mice show exacerbated ischemia and reperfusion injury. Neuroscience 185:116-124.
37. Paskowitz DM, LaVail MM, Duncan JL. 2006. Light and inherited retinal degeneration. Br J Ophthalmol 90:1060-1066.
38. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ, D'Amore PA. 2008. Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One 3:e3554.
39. Sanvicens N, Gomez-Vicente V, Masip I, Messeguer A, Cotter TG. 2004. Oxidative stress-induced apoptosis in retinal photoreceptor cells is mediated by calpains and caspases and blocked by the oxygen radical scavenger CR-6. J Biol Chem 279:39268-39278.
40. Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK. 2003. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102:1515-1524.
41. Sharma AK, Rohrer B. 2004. Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem 279:35564-35572.
42. Shimazawa M, Inokuchi Y, Ito Y, Murata H, Aihara M, Miura M, Araie M, Hara H. 2007. Involvement of ER stress in retinal cell death. Mol Vis 13:578-587.
43. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man W.Y, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, Robberecht W, Conway EM, Collen D, Moons L, Carmeliet P. 2005. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8:85-92.
44. Sundberg LM, Herrera JJ, Narayana PA. 2011. Effect of vascular endothelial growth factor treatment in experimental traumatic spinal cord injury: in vivo longitudinal assessment. J Neurotrauma 28:565-578.
45. Takano N, Tsuruma K, Ohno Y, Shimazawa M, Hara H. 2013. Bimatoprost protects retinal neuronal damage via Akt pathway. Eur J Pharmacol 702:56-61.
46. Tanaka H, Shimazawa M, Kimura M, Takata M, Tsuruma K, Yamada M, Takahashi H, Hozumi I, Niwa J, Iguchi Y, Nikawa T, Sobue G, Inuzuka T, Hara H. 2012. The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis. Sci Rep 2:573.
47. Taylor AP, Leon E, Goldenberg DM. 2010. Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement. Br J Cancer 103:82-89.
48. Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR. 2010. Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. J Cereb Blood Flow Metab 30:1008-1016.
49. Wang G, Jiang X, Pu H, Zhang W, An C, Hu X, Liou AK, Leak RK, Gao Y, Chen J. 2013. Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway. Neurotherapeutics 10:124-142.
50. Wenzel A, Grimm C, Samardzija M, Reme CE. 2005. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Ret Eye Res 24:275-306.
51. Yang JH, Basinger SF, Gross RL, Wu SM. 2003. Blue light-induced generation of reactive oxygen species in photoreceptor ellipsoids requires mitochondrial electron transport. Invest Ophthalmol Vis Sci 44:1312-1319.
52. Zulliger R, Lecaude S, Eigeldinger-Berthou S, Wolf-Schnurrbusch UE, Enzmann V. 2013. Caspase-3-independent photoreceptor degeneration by N-methyl-N-nitrosourea (MNU) induces morphological and functional changes in the mouse retina. Graefes Arch Clin Exp Ophthalmol 249:859-869.